Want to see HK:1833 full AI Analyst Report?
Top Page
Ping An Healthcare and Technology Company
(1833)
Select Model
Select Model
Rating:57Neutral
Price Target:
HK$5.50
▼(-17.17% Downside)
Action:Reiterated
Date:08/21/26
The overall score is supported primarily by improving financial performance (return to profitability, stronger 2025 results, and very low leverage with improving cash flow), but is held back materially by weak technicals (price below all key moving averages and negative MACD). Valuation is only moderate given a 25.65 P/E and no dividend yield provided.
Positive Factors
Profitability turnaround
The shift from repeated losses to positive and improving net income indicates a meaningful operating turnaround. Steady gross margins of about 31–32%, positive 2025 EBIT, and higher EBITDA suggest the improvement is supported by underlying profitability rather than a single isolated result.
Negative Factors
Volatile revenue trajectory
The uneven revenue path makes the company’s growth profile less dependable than its margin and profit recovery. Sharp earlier contraction followed by only modest 2024 growth indicates that sustained demand expansion is not yet as established, which could limit the durability of future earnings gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability turnaround
The shift from repeated losses to positive and improving net income indicates a meaningful operating turnaround. Steady gross margins of about 31–32%, positive 2025 EBIT, and higher EBITDA suggest the improvement is supported by underlying profitability rather than a single isolated result.
Read all positive factors
Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$11.76B
Dividend Yield160.6%
Average Volume (3M)7.25M
Price to Earnings (P/E)21.0
Beta (1Y)1.08
Revenue Growth7.92%
EPS Growth152.75%
CountryHK
Employees1,586
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.22
Shares Outstanding2,161,443,600
10 Day Avg. Volume6,846,524
30 Day Avg. Volume7,246,341
Financial Highlights & Ratios
PEG Ratio0.50
Price to Book (P/B)2.63
Price to Sales (P/S)4.77
P/FCF Ratio66.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$11.27Price Target Upside69.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.13
Revenue Forecast (FY)HK$4.92B
Ping An Healthcare and Technology Company Business Overview & Revenue Model
Company Description
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical cons...
Ping An Healthcare and Technology Company Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
82
Very Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.42B | 5.47B | 4.81B | 4.67B | 6.21B | 7.33B |
| Gross Profit | 1.88B | 1.77B | 1.52B | 1.51B | 1.67B | 1.71B |
| EBITDA | 383.75M | 285.76M | 193.43M | -164.23M | -932.04M | -1.63B |
| Net Income | 461.65M | 379.51M | 81.43M | -322.59M | -636.06M | -1.54B |
Balance Sheet | ||||||
| Total Assets | 13.08B | 13.24B | 16.78B | 16.52B | 17.14B | 17.88B |
| Cash, Cash Equivalents and Short-Term Investments | 7.20B | 6.97B | 11.52B | 11.35B | 10.14B | 10.14B |
| Total Debt | 29.05M | 39.81M | 45.00M | 93.61M | 176.49M | 201.29M |
| Total Liabilities | 3.01B | 3.33B | 13.20B | 3.25B | 3.68B | 3.79B |
| Stockholders Equity | 10.08B | 9.92B | 3.59B | 13.28B | 13.46B | 14.08B |
Cash Flow | ||||||
| Free Cash Flow | 344.67M | 391.83M | 65.08M | -325.82M | -845.05M | -1.49B |
| Operating Cash Flow | 387.36M | 430.72M | 99.33M | -282.86M | -810.62M | -1.40B |
| Investing Cash Flow | 1.23B | 3.04B | 114.65M | -1.49B | 1.71B | -3.10B |
| Financing Cash Flow | -113.55M | -3.84B | -38.44M | -67.36M | -317.88M | -319.91M |
Ping An Healthcare and Technology Company Technical Analysis
Negative
6.64
Price Trends
6.08
Negative
6.86
Negative
9.64
Negative
Market Momentum
-0.23
Positive
35.07
Neutral
14.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Negative. The current price of 6.64 is above the 20-day moving average (MA) of 5.74, above the 50-day MA of 6.08, and below the 200-day MA of 9.64, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 35.07 is Neutral, neither overbought nor oversold. The STOCH value of 14.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1833.
Ping An Healthcare and Technology Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$4.67B | 11.63 | 7.05% | 4.98% | 6.47% | 8.10% | |
70 Outperform | HK$1.43B | 8.01 | 43.78% | 12.76% | -14.68% | -13.60% | |
57 Neutral | HK$11.76B | 20.98 | 4.62% | 160.60% | 7.92% | 152.75% | |
56 Neutral | HK$1.10B | -15.52 | -3.87% | ― | 8.73% | 80.38% | |
52 Neutral | HK$3.05B | 36.94 | 1.88% | 1.40% | 16.87% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:1833
Ping An Healthcare and Technology Company
5.44
-8.98
-62.27%
HK:9886
Dingdang Health Technology Group Ltd.
0.90
-0.19
-17.43%
HK:1830
Perfect Medical Health Management Limited
1.14
-0.08
-6.79%
HK:2158
Yidu Tech, Inc.
2.86
-2.95
-50.77%
HK:2192
Medlive Technology Co., Ltd.
6.31
-4.03
-38.99%
HK:2506
Xunfei Healthcare Technology Co., Ltd.
64.15
-22.05
-25.58%
Ping An Healthcare and Technology Company Corporate Events
Ping An Healthcare Proposes Overhaul of Articles to Meet Hong Kong Paperless Regime
Oct 22, 2026
Ping An Healthcare and Technology Company Limited has proposed adopting an amended and restated memorandum and articles of association to replace its existing constitutional documents. The move is designed to align the company’s share struct...
Ping An Healthcare Moves China Head Office to Shenzhen Tech Hub
Oct 22, 2026
Ping An Healthcare and Technology Company Limited announced that it will relocate its head office and principal place of business in China to new premises in the Ping An Credit Card Building on Menghai Avenue in Shenzhen, effective 23 November 202...
Ping An Healthcare Lifts Profit on Corporate Health Push and AI-Powered Services
Oct 22, 2026
Ping An Healthcare and Technology reported a 5.8% drop in revenue to RMB3.51 billion for the nine months ended 30 September 2026, but net profit surged 35% to RMB248 million and adjusted net profit rose 19.5% to RMB258 million. The group saw stron...
Ping An Healthcare Renews 2026 Connected Transaction Frameworks With Controlling Shareholder
Sep 28, 2026
Ping An Healthcare and Technology Company Limited has proposed renewing a suite of intragroup framework agreements with its controlling shareholder Ping An and its life insurance affiliate, covering the provision and purchase of products and servi...
Ping An Healthcare Sets Board Meeting to Approve Q3 2026 Results
Sep 21, 2026
Ping An Healthcare and Technology Company Limited has scheduled a board meeting for 22 October 2026 in Shanghai to review and approve the unaudited third‑quarter results for the nine months ended 30 September 2026. The meeting will also cove...
Ping An Healthcare Sets Out Board and Committee Structure
Aug 18, 2026
Ping An Healthcare and Technology Company Limited has announced the current composition of its board of directors and clarified the roles of executive, non-executive, and independent non-executive members. The board is led by chairman Yougang Zhu ...
Ping An Healthcare Overhauls Board with New Leadership from Ping An Group
Aug 18, 2026
Ping An Healthcare and Technology Company Limited announced extensive board changes, with five directors, including several non-executive and an independent non-executive director, resigning effective 19 August 2026 due to personal work arrangemen...
Ping An Healthcare and Technology Publishes Unaudited 2026 Interim Results
Aug 18, 2026
Ping An Healthcare and Technology Company Limited, a Hong Kong-listed provider of technology-enabled healthcare services, operates within the broader Ping An Group framework and targets the mainland Chinese market. The company is incorporated in t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.